Beam Therapeutics Inc. (BEAM)

Beam Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	281.97	435.9	232.77	559.99	162.17
Short-Term Investments	568.77	753.98	845.37	405.65	137.5
Cash & Short-Term Investments	850.74	1,190	1,078	965.65	299.67
Cash Growth	-28.50%	10.36%	11.65%	222.24%	226.27%
Receivables	-	-	-	300	-
Prepaid Expenses	27.41	21.17	14.76	7.36	8.65
Total Current Assets	878.15	1,211	1,093	1,273	308.32
Property, Plant & Equipment	216.28	237.81	234.13	186.98	125.37
Other Long-Term Assets	9.4	10.87	14.69	14.47	17.98
Total Assets	1,104	1,460	1,342	1,474	451.68
Accounts Payable	3.87	1.62	9.03	7.47	6.31
Accrued Expenses	36.13	35.05	30.72	56.87	11.96
Current Portion of Leases	13.47	12.78	12.23	9.83	6.34
Current Unearned Revenue	108.86	68.71	135.97	86.27	0.02
Other Current Liabilities	19.74	87.42	35.64	53	77.7
Total Current Liabilities	182.07	205.57	223.6	213.44	102.34
Long-Term Leases	147.96	159.91	168.63	137.82	101.31
Long-Term Unearned Revenue	33.22	109.89	202.18	262.3	0.39
Other Long-Term Liabilities	7.04	3.02	13.84	34.16	2.08
Total Liabilities	370.28	478.39	608.24	647.72	206.12
Common Stock	0.84	0.82	0.71	0.68	0.57
Additional Paid-In Capital	2,299	2,170	1,793	1,594	642.63
Retained Earnings	-1,567	-1,190	-1,057	-768.27	-397.64
Comprehensive Income & Other	0.68	0.6	-2.43	-0.05	-0.01
Total Common Equity	733.55	981.33	733.47	826.74	245.56
Shareholders' Equity	733.55	981.33	733.47	826.74	245.56
Total Liabilities & Equity	1,104	1,460	1,342	1,474	451.68
Total Debt	161.43	172.69	180.86	147.64	107.64
Net Cash (Debt)	689.32	1,017	897.28	818	192.03
Net Cash Growth	-32.23%	13.36%	9.69%	325.98%	216.82%
Net Cash Per Share	8.37	13.18	12.82	12.74	4.11
Filing Date Shares Outstanding	81.11	78.73	70.7	67.6	61.14
Total Common Shares Outstanding	81.06	78.71	69.58	67.26	55.98
Working Capital	696.08	1,005	869.3	1,060	205.98
Book Value Per Share	9.05	12.47	10.54	12.29	4.39
Tangible Book Value	733.55	981.33	733.47	826.74	245.56
Tangible Book Value Per Share	9.05	12.47	10.54	12.29	4.39
Machinery	79.79	69.67	54.79	35.23	18.83
Construction In Progress	2.53	5.28	5.2	7.35	15.88
Leasehold Improvements	101.2	100.19	85.8	57.76	12.71

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q